(NASDAQ: GLPG) Galapagos Nv's forecast annual revenue growth rate of 6.93% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Galapagos Nv's revenue in 2024 is $260,569,565.On average, 4 Wall Street analysts forecast GLPG's revenue for 2024 to be $30,849,845,583, with the lowest GLPG revenue forecast at $18,200,771,010, and the highest GLPG revenue forecast at $40,295,399,946. On average, 3 Wall Street analysts forecast GLPG's revenue for 2025 to be $22,629,713,152, with the lowest GLPG revenue forecast at $18,445,249,144, and the highest GLPG revenue forecast at $26,093,922,175.
In 2026, GLPG is forecast to generate $22,377,063,782 in revenue, with the lowest revenue forecast at $18,686,432,423 and the highest revenue forecast at $26,283,705,739.